Products
Online Inquiry
Motesanib diphosphate (AMG-706)
Cat. No.:
OB0225WX-2388
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and HPLC.
Size:
Add to basket
Product Overview
Description:
Motesanib diphosphate is a potent, ATP-competitive inhibitor of VEGFR1, 2, and 3 (IC50: 2, 3, and 6 nM) with comparable activity against c-Kit and high selectivity over PDGFR.
Synonym:
857876-30-3; Motesanib diphosphate; AMG-706; Motesanib (Diphosphate); Motesanib Diphosphate (AMG-706); Motesanib phosphate; AMG 706 (Diphosphate); AMG706; 3-Pyridinecarboxamide, N-(2,3-dihydro-3,3-dimethyl-1H-indol-6-yl)-2-((4-pyridinylmethyl)amino)-, phosphate (1:2); N-(3,3-dimethyl-1,2-dihydroindol-6-yl)-2-(pyridin-4-ylmethylamino)pyridine-3-carboxamide;phosphoric acid; MOTESANIB DIPHOSPHATE (MART.); N-(3,3-Dimethylindolin-6-yl)-2-((pyridin-4-ylmethyl)amino)nicotinamide diphosphate; N-(3,3-Dimethyl-2,3-dihydro-1H-indol-6-yl)-2-((pyridin-4-ylmethyl)amino)pyridine-3-carboxamide diphosphate; N-(3,3-Dimethyl-2,3-dihydro-1H-indol-6-yl)-2-[(pyridin-4-ylmethyl)amino]pyridine-3-carboxamide diphosphate; MFCD12407403; N-(3,3-dimethyl-1,2-dihydroindol-6-yl)-2-(pyridin-4-ylmethylamino)pyridine-3-carboxamide,phosphoric acid; N-(3,3-dimethylindolin-6-yl)-2-(pyridin-4-ylmethylamino)nicotinamide bis(phosphate); N-(3,3-Dimethyl-1,2-dihydroindol-6-yl)-2-(pyridin-4-ylmethylamino)pyridine-3-carboxamide diphosphate; N-(3,3-dimethyl-2,3-dihydro-1H-indol-6-yl)-2-((pyridin-4-ylmethyl)amino)pyridine-3-carboxamide phosphate (1:2)
CAS No.:
857876-30-3
Compound CID:
16097729
Formula:
C22H23N5O·2H3PO4
Formula Weight:
569.44
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Motesanib diphosphate is used in oncological studies as a potent inhibitor of VEGF, PDGF, and Kit receptors to investigate the disruption of vascular development and the suppression of solid tumor xenografts.
Library Information
Target:
c-Kit; PDGFR; VEGFR
Receptor:
c-Kit; PDGFR; VEGFR
Pathways:
Protein tyrosine kinase
Plate Number:
L6700-01
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
100 mg/mL; 175.61 mM
Water Max Solubility:
19 mg/mL; 33.37 mM
ALogP:
1.783
HBA_Count:
3
HBD_Count:
3
Rotatable Bond:
5





